Transfusion Compatibility Testing and Crossmatch

Compatibility testing is the sequence of laboratory steps that confirms a unit of donor blood is safe to transfuse into a particular recipient. It combines ABO and Rh typing, an antibody screen, and a crossmatch so that transfused red cells are not destroyed by the recipient's antibodies.

Definition

Transfusion compatibility testing is the laboratory process of determining a recipient's ABO and Rh type, screening their plasma for unexpected antibodies, and verifying by crossmatch that a selected donor unit is compatible before the unit is issued for transfusion.

Scope

This topic covers the pre-transfusion workflow: sample identification, ABO/Rh grouping, antibody screening, and the serological or electronic crossmatch, together with the logic of the type-and-screen approach. It is a reference description of how compatibility is established and does not set transfusion triggers or component-selection policy.

Core questions

• What steps make up pre-transfusion compatibility testing?
• What is the difference between a serological and an electronic crossmatch?
• When is a full antiglobulin crossmatch required rather than an immediate-spin or electronic check?
• How does the type-and-screen approach support safe and efficient blood provision?

Key concepts

• ABO and Rh grouping
• Antibody screen
• Serological (antiglobulin) crossmatch
• Immediate-spin crossmatch
• Electronic (computer) crossmatch
• Type and screen
• Sample and patient identification

Mechanisms

Compatibility testing builds safety in layers. The recipient's ABO and Rh type is determined and their plasma is screened for unexpected antibodies. If the screen is negative and records concur, ABO/Rh-compatible units can often be released by an electronic crossmatch that relies on validated computer logic, or by an immediate-spin crossmatch that confirms ABO compatibility. If the screen is positive or the patient is alloimmunised, antigen-negative units are selected and a full antiglobulin crossmatch is performed, in which donor red cells are incubated with recipient plasma and tested in the antiglobulin phase to confirm no reaction. Correct identification of the patient and sample is the foundation on which all of these steps depend, because most fatal incompatible transfusions stem from misidentification rather than serological error.

Clinical relevance

Compatibility testing is how transfusion services prevent acute haemolytic reactions due to incompatible red cells. This entry describes the laboratory logic of grouping, screening, and crossmatching; decisions about whether and what to transfuse, and management of transfusion reactions, fall under clinical guidelines and are not given here.

Epidemiology

Acute haemolytic transfusion reactions are now rare where structured compatibility testing and identification controls are in place, and surviving cases are most often attributable to clerical or identification errors, underscoring the role of process as well as serology. Haemovigilance schemes track these and other transfusion hazards.

Evidence & guidelines

Pre-transfusion testing is codified in standards and reference texts such as the AABB Technical Manual and Mollison's Blood Transfusion in Clinical Medicine, while the indications and hazards of transfusion are summarised in clinical reviews. These sources describe consensus practice.

History

Routine crossmatching followed Landsteiner's discovery of the ABO groups and the recognition that incompatible transfusion caused haemolysis. The antiglobulin test extended crossmatching to incomplete antibodies from 1945 onward, and later decades introduced the type-and-screen strategy and, with reliable computerised records, the electronic crossmatch, increasing both safety and efficiency.

Key figures

• Karl Landsteiner
• Patrick Mollison
• Harvey Klein

Seminal works

• mollison-2014
• carson-2017
• panch-2019

Frequently asked questions

What is a type and screen?

A type and screen determines a recipient's ABO and Rh group and screens their plasma for unexpected antibodies; if negative, compatible units can often be issued quickly without a full serological crossmatch.

What is an electronic crossmatch?

An electronic crossmatch uses validated computer logic to confirm ABO/Rh compatibility between recipient and donor records when the antibody screen is negative, replacing a physical serological crossmatch under defined conditions.